1. Home
  2. SIMO vs MYGN Comparison

SIMO vs MYGN Comparison

Compare SIMO & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Silicon Motion Technology Corporation

SIMO

Silicon Motion Technology Corporation

HOLD

Current Price

$125.80

Market Cap

4.3B

Sector

Technology

ML Signal

HOLD

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

HOLD

Current Price

$4.67

Market Cap

481.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SIMO
MYGN
Founded
1995
1991
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.3B
481.6M
IPO Year
2005
1996

Fundamental Metrics

Financial Performance
Metric
SIMO
MYGN
Price
$125.80
$4.67
Analyst Decision
Strong Buy
Buy
Analyst Count
9
8
Target Price
$114.38
$7.64
AVG Volume (30 Days)
427.1K
1.6M
Earning Date
04-28-2026
05-05-2026
Dividend Yield
1.59%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$771,400,000.00
Revenue This Year
$46.00
$7.19
Revenue Next Year
$13.84
$5.64
P/E Ratio
$36.09
N/A
Revenue Growth
N/A
2.33
52 Week Low
$37.21
$3.76
52 Week High
$146.85
$10.30

Technical Indicators

Market Signals
Indicator
SIMO
MYGN
Relative Strength Index (RSI) 51.11 43.84
Support Level $84.79 $3.93
Resistance Level $145.77 $5.63
Average True Range (ATR) 5.66 0.35
MACD -0.54 0.01
Stochastic Oscillator 64.06 30.77

Price Performance

Historical Comparison
SIMO
MYGN

About SIMO Silicon Motion Technology Corporation

Silicon Motion Technology Corp is engaged in developing NAND flash controllers for SSDs and other solid state storage devices. Its only operating segment is to develop NAND flash controllers and SSDs solutions. The company derives revenue from product categories such as Mobile Storage, Mobile Communications, and others. Silicon's geographical segments are Taiwan, the United States, Korea, China, Singapore, Malaysia, and others. The company products are used in Personal Computing, Smartphone/Tablet/CE, Flash Card/USB Flash Drive, Industrial and Embedded, Automotive, and Enterprise and Data centers.

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.

Share on Social Networks: